{"cik":1318641,"taxonomy":"us-gaap","tag":"ContractWithCustomerLiabilityCurrent","label":"Contract with Customer, Liability, Current","description":"Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.","entityName":"Statera Biopharma, Inc.","units":{"USD":[{"end":"2020-09-30","val":6825,"accn":"0001437749-20-023890","fy":2020,"fp":"Q3","form":"10-Q","filed":"2020-11-16","frame":"CY2020Q3I"},{"end":"2020-12-30","val":0,"accn":"0001437749-21-026749","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15"},{"end":"2020-12-31","val":0,"accn":"0001437749-22-023703","fy":2021,"fp":"FY","form":"10-K","filed":"2022-10-06","frame":"CY2020Q4I"},{"end":"2021-09-30","val":506032,"accn":"0001437749-21-026749","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"},{"end":"2021-12-31","val":373468,"accn":"0001437749-22-023703","fy":2021,"fp":"FY","form":"10-K","filed":"2022-10-06"},{"end":"2021-12-31","val":373468,"accn":"0001437749-22-024497","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-10-21"},{"end":"2021-12-31","val":373468,"accn":"0001437749-22-025006","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-10-28"},{"end":"2021-12-31","val":373468,"accn":"0001437749-22-027371","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-14","frame":"CY2021Q4I"},{"end":"2022-03-31","val":205825,"accn":"0001437749-22-024497","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-10-21","frame":"CY2022Q1I"},{"end":"2022-06-30","val":550215,"accn":"0001437749-22-025006","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-10-28","frame":"CY2022Q2I"},{"end":"2022-09-30","val":386929,"accn":"0001437749-22-027371","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-14","frame":"CY2022Q3I"}]}}